XML 113 R145.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Schedule of Condensed Consolidating Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net cash provided by (used for) operating activities $ 32,376 $ 42,069 $ (18,909)
Cash flows from investing activities:      
Proceeds from sale of fixed maturities 977,321 293,348 918,439
Proceeds from sale of equity securities 260,891 35,639 32,218
Proceeds from maturity of fixed maturities 180,546 55,182 145,475
Proceeds from other invested assets 16,757 43,377 12,299
Amount received (paid) in connection with derivatives (7,654) 4,392 1,464
Purchases of fixed maturities (1,129,567) (370,536) (1,078,199)
Purchases of equity securities (365,255) (36,258) (36,647)
Purchases of other invested assets (13,283) (16,309) (24,000)
Acquisition of business 0 (3,515) 0
Net cash provided by (used for) investing activities (80,244) 5,320 (28,951)
Cash flows from financing activities:      
Net borrowings (repayments) under margin borrowing facility 7,811 (6,412) 5,584
Redemption of ordinary shares 0 0 (83,015)
Proceeds from issuance of subordinated notes 0 0 130,000
Debt issuance cost 0 0 (4,246)
Dividends paid to shareholders (14,222) (14,027) 0
Capital contribution 0   0
Purchase of A ordinary shares (947) (1,867) (1,159)
Net cash provided by (used for) financing activities (7,358) (22,306) 47,164
Proceeds / (issuance) of notes to affiliates   0 0
Debt restructuring   0  
Dividends from subsidiaries   0 0
Net change in cash and cash equivalents (55,226) 25,083 (696)
Cash and cash equivalents at beginning of period 99,497 74,414 75,110
Cash and cash equivalents at end of period 44,271 99,497 74,414
Global Indemnity Limited (Parent co-obligor) | Reportable Legal Entities      
Cash flows from operating activities:      
Net cash provided by (used for) operating activities 2,632 (20,178) (24,927)
Cash flows from investing activities:      
Proceeds from sale of fixed maturities 48,393 32,980 12,389
Proceeds from sale of equity securities 10,900 0 0
Proceeds from maturity of fixed maturities 0 5,431 10,000
Proceeds from other invested assets 4,363 1,500 0
Amount received (paid) in connection with derivatives 0 0 0
Purchases of fixed maturities (10,548) (33,327) (32,044)
Purchases of equity securities (41,815) 0 0
Purchases of other invested assets 0 0 0
Acquisition of business   0  
Net cash provided by (used for) investing activities 11,293 6,584 (9,655)
Cash flows from financing activities:      
Net borrowings (repayments) under margin borrowing facility 0 0 0
Redemption of ordinary shares     (83,015)
Proceeds from issuance of subordinated notes     130,000
Debt issuance cost     (4,246)
Dividends paid to shareholders (14,222) (14,027)  
Capital contribution 0   (96,000)
Purchase of A ordinary shares (947) (1,867) (1,159)
Net cash provided by (used for) financing activities (15,169) 4,726 45,580
Proceeds / (issuance) of notes to affiliates   230,000 0
Debt restructuring   (230,000)  
Dividends from subsidiaries   20,620 100,000
Net change in cash and cash equivalents (1,244) (8,868) 10,998
Cash and cash equivalents at beginning of period 2,221 11,089 91
Cash and cash equivalents at end of period 977 2,221 11,089
Global Indemnity Group, LLC (Subsidiary co-obligor) | Reportable Legal Entities      
Cash flows from operating activities:      
Net cash provided by (used for) operating activities (23,295) (35,207) (37,165)
Cash flows from investing activities:      
Proceeds from sale of fixed maturities 101,584 71,900 54,082
Proceeds from sale of equity securities 249,991 35,639 32,218
Proceeds from maturity of fixed maturities 0 7,600 78,925
Proceeds from other invested assets 12,394 34,499 4,139
Amount received (paid) in connection with derivatives (7,654) 4,392 1,464
Purchases of fixed maturities (26,205) (40,858) (254,152)
Purchases of equity securities (311,711) (36,258) (36,647)
Purchases of other invested assets (13,283) (15,800) (22,500)
Acquisition of business   (3,515)  
Net cash provided by (used for) investing activities 5,116 57,599 (142,471)
Cash flows from financing activities:      
Net borrowings (repayments) under margin borrowing facility 7,811 (6,412) 5,584
Redemption of ordinary shares     0
Proceeds from issuance of subordinated notes     0
Debt issuance cost     0
Dividends paid to shareholders 0 0  
Capital contribution (13,008)   0
Purchase of A ordinary shares 0 0 0
Net cash provided by (used for) financing activities (5,197) (4,102) 181,849
Proceeds / (issuance) of notes to affiliates   (227,690) 120,000
Debt restructuring   230,000  
Dividends from subsidiaries   0 56,265
Net change in cash and cash equivalents (23,376) 18,290 2,213
Cash and cash equivalents at beginning of period 26,039 7,749 5,536
Cash and cash equivalents at end of period 2,663 26,039 7,749
Other Global Indemnity Limited Subsidiaries and Eliminations (non-co-obligor subsidiaries)      
Cash flows from operating activities:      
Net cash provided by (used for) operating activities [1] 53,039 97,454 43,183
Cash flows from investing activities:      
Proceeds from sale of fixed maturities [1] 827,344 188,468 851,968
Proceeds from sale of equity securities [1] 0 0 0
Proceeds from maturity of fixed maturities [1] 180,546 42,151 56,550
Proceeds from other invested assets [1] 0 7,378 8,160
Amount received (paid) in connection with derivatives [1] 0 0 0
Purchases of fixed maturities [1] (1,092,814) (296,351) (792,003)
Purchases of equity securities [1] (11,729) 0 0
Purchases of other invested assets [1] 0 (509) (1,500)
Acquisition of business [1]   0  
Net cash provided by (used for) investing activities [1] (96,653) (58,863) 123,175
Cash flows from financing activities:      
Net borrowings (repayments) under margin borrowing facility [1] 0 0 0
Redemption of ordinary shares [1]     0
Proceeds from issuance of subordinated notes [1]     0
Debt issuance cost [1]     0
Dividends paid to shareholders [1] 0 0  
Capital contribution [1] 13,008   96,000
Purchase of A ordinary shares [1] 0 0 0
Net cash provided by (used for) financing activities [1] 13,008 (22,930) (180,265)
Proceeds / (issuance) of notes to affiliates [1]   (2,310) (120,000)
Debt restructuring [1]   0  
Dividends from subsidiaries [1]   (20,620) (156,265)
Net change in cash and cash equivalents [1] (30,606) 15,661 (13,907)
Cash and cash equivalents at beginning of period [1] 71,237 55,576 69,483
Cash and cash equivalents at end of period [1] $ 40,631 $ 71,237 $ 55,576
[1] Includes all other subsidiaries of Global Indemnity Limited and eliminations